Sexually Transmitted Infections · 2026-07-16
Research news in clinical context
Phrase rank #1 · DOI 10.1136/sextrans-2025-056817
Other observed topics
HCC
Observed in 147 articles across 12 journals.
Latest share0.39%
Change vs baseline-0.20 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Gut77
- Journal for ImmunoTherapy of Cancer39
- Frontline Gastroenterology13
- BMJ Open6
- BMJ Case Reports4
- Sexually Transmitted Infections2
- BMJ Global Health1
- BMJ Open Gastroenterology1
- BMJ Public Health1
- eGastroenterology1
- European Journal of Hospital Pharmacy1
- Journal of Clinical Pathology1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Journal for ImmunoTherapy of Cancer · 2026-06-28
Lithocholic acid-activated VDR in macrophages promotes HCC recurrence post-ablation via SOCS3-mediated suppression of CXCL16
Phrase rank #1 · DOI 10.1136/jitc-2026-015177
Gut · 2026-06-26
IDDF2026-ABS-0433 MYEF2 stabilizes MAP2K6 mRNA to drive cholesterol-dependent cancer stemness in hepatocellular carcinoma
Phrase rank #1 · DOI 10.1136/gutjnl-2026-IDDF.45
Gut · 2026-06-23
P121 Association between occupational exposure and hepatocellular carcinoma risk in Egypt: a preliminary case–control analysis
Phrase rank #1 · DOI 10.1136/gutjnl-2026-BSG.254
Gut · 2026-06-23
P76 Role of metabolic dysfunction-associated steatohepatitis as a risk factor for hepatocellular carcinoma development
Phrase rank #1 · DOI 10.1136/gutjnl-2026-BSG.212
eGastroenterology · 2026-05-29
Immunotherapy in HCC: aetiology matters
Phrase rank #1 · DOI 10.1136/egastro-2026-100465
Gut · 2026-05-17
12-HETE: a novel lipid mediator of CD8+ T cell dysfunction in MASH/HCC
Phrase rank #1 · DOI 10.1136/gutjnl-2025-337730
Journal for ImmunoTherapy of Cancer · 2026-04-09
RNA helicase SKIV2L impedes tumor immunity by reprogramming arginine metabolism of hepatocellular carcinomas
Phrase rank #1 · DOI 10.1136/jitc-2025-014192
Journal for ImmunoTherapy of Cancer · 2026-03-24
Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma
Phrase rank #1 · DOI 10.1136/jitc-2024-010841
Journal for ImmunoTherapy of Cancer · 2026-02-17
Modulating Bacteroides to boost anti-PD-1 immunotherapy in HCC
Phrase rank #1 · DOI 10.1136/jitc-2025-013755
Journal for ImmunoTherapy of Cancer · 2026-01-27
Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis
Phrase rank #1 · DOI 10.1136/jitc-2025-011997
Journal for ImmunoTherapy of Cancer · 2025-12-18
PINK1 dysfunction in hepatocellular carcinoma fosters immune evasion and disease progression by promoting neutrophil infiltration
Phrase rank #1 · DOI 10.1136/jitc-2025-013079
Journal for ImmunoTherapy of Cancer · 2025-11-28
Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression
Phrase rank #1 · DOI 10.1136/jitc-2025-012586
Journal for ImmunoTherapy of Cancer · 2025-11-04
49 Complement system alterations in hepatocellular carcinoma (HCC): insights from mRNA-proteome integration and receptor blockade studies
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.0049
Journal for ImmunoTherapy of Cancer · 2025-11-04
1205 PLT012, a humanized CD36-blocking antibody, induces durable anti-tumor immunity via immunometabolic reprogramming
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.1205
Gut · 2025-10-06
P52 Lower expression of beta klotho is associated with worse overall survival in hepatocellular carcinoma in North of Scotland cohort
Phrase rank #1 · DOI 10.1136/gutjnl-2025-BASL.68
Gut · 2025-10-06
P56 A retrospective review of potential missed opportunities for earlier diagnosis of liver cirrhosis in patients with hepatocellular carcinoma (HCC)
Phrase rank #1 · DOI 10.1136/gutjnl-2025-BASL.72
Gut · 2025-07-29
Partial cure of chronic hepatitis B: potential implications for HCC surveillance?
Phrase rank #1 · DOI 10.1136/gutjnl-2025-336032
Frontline Gastroenterology · 2026-07-02
Diagnostic routes for hepatocellular carcinoma in the UK: a multicentre evaluation
Phrase rank #2 · DOI 10.1136/flgastro-2026-103782
Gut · 2026-06-26
IDDF2026-ABS-0188 SLC26A6 promotes the carcinogenesis and growth of hepatocellular carcinoma through modulating lipid metabolism and FOS/JUN signaling
Phrase rank #2 · DOI 10.1136/gutjnl-2026-IDDF.27
Gut · 2026-06-26
IDDF2026-ABS-0048 Exploring practices and attitudes towards stopping hepatocellular carcinoma surveillance: a multinational clinician survey with over 500 respondents
Phrase rank #2 · DOI 10.1136/gutjnl-2026-IDDF.173
Gut · 2026-06-25
Targeting NEK9 synergises with immunotherapy in hepatocellular carcinoma by remodelling the immunosuppressive microenvironment
Phrase rank #2 · DOI 10.1136/gutjnl-2026-338449
Gut · 2026-06-23
P85 Effectiveness of antiviral therapy in reducing incidence of de-novo HCC in patients with compensated HCV-related cirrhosis: systematic review and meta-analysis
Phrase rank #2 · DOI 10.1136/gutjnl-2026-BSG.221
BMJ Public Health · 2026-06-11
Care-seeking among hepatocellular carcinoma patients in Uganda: health system navigation and its impact on diagnosis and survival in a prospective case-cohort study
Phrase rank #2 · DOI 10.1136/bmjph-2025-004527
Gut · 2026-05-12
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study
Phrase rank #2 · DOI 10.1136/gutjnl-2025-336719
Journal for ImmunoTherapy of Cancer · 2026-05-04
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma
Phrase rank #2 · DOI 10.1136/jitc-2025-014555
Gut · 2026-04-07
KIF1Bβ suppresses hepatocellular carcinoma by transporting and secreting FBLN5 to attenuate the integrin pathway
Phrase rank #2 · DOI 10.1136/gutjnl-2025-336230
Journal for ImmunoTherapy of Cancer · 2026-03-27
Liver-directed AAV-IL-10 therapy enhances CD8+ T cell-mediated immunity against hepatocellular carcinoma
Phrase rank #2 · DOI 10.1136/jitc-2025-012460
Gut · 2026-01-02
CD48 is a novel immune checkpoint on tumour‐associated macrophages in hepatocellular carcinoma
Phrase rank #2 · DOI 10.1136/gutjnl-2025-336744
Journal for ImmunoTherapy of Cancer · 2025-11-04
183 Fresh tumor analysis enables rapid characterization of prognostic subgroups and identifies novel therapeutic targets for early-stage hepatocellular carcinoma
Phrase rank #2 · DOI 10.1136/jitc-2025-SITC2025.0183